AF.87 RESIST-HCV CRITERIA ARE ABLE TO RULE OUT ESOPHAGEAL VARICES PROGRESSION IN PATIENTS WITH HCV CIRRHOSIS TREATED BY DIRECT-ACTING ANTIVIRAL AGENTS(DAAS). (September 2021) - Calvaruso, V.; Petta, S.; Licata, M.; Simone, F.; Di Marco, L.; Crapanzano, L.; Di Martino, V.; Abdel Hadi, Y.; Cammà, C.; Craxì, A.; Di Marco, V.